BeStock  

Bioventus BVS

US equityMarket cap rank #3408Medical Devices
$9.88 −$0.07 (-0.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.88 0.00%
Open$9.85
Prev close$9.95
Day range$9.81 – $10.17
Volume612.4K
Market cap$676.53M
P/E (TTM)12.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$142.44M+2.7% YoY
Operating profit$9.70M-13.8% YoY
Net profit$6.86M+71.2% YoY
Diluted EPS$0.08+60.0% YoY
Free cash flow$20.32M-31.4% YoY
Operating cash flow$20.66M

Revenue, last 8 quarters

$153.6MDec '24$123.9MMar '25$147.7MJun '25$138.7MSep '25$157.9MDec '25$132.1MMar '26$153.2MJun '26$142.4MSep '26

Net profit, last 8 quarters

$-603.0KDec '24$-3.3MMar '25$9.3MJun '25$4.0MSep '25$17.3MDec '25$3.9MMar '26$36.2MJun '26$6.9MSep '26

Diluted EPS by quarter

0.00Dec '24-0.04Mar '250.11Jun '250.05Sep '250.21Dec '250.04Mar '260.47Jun '260.08Sep '26

Free cash flow by quarter

$18.7MDec '24$-20.2MMar '25$25.3MJun '25$29.6MSep '25$37.4MDec '25$8.4MMar '26$18.9MJun '26$20.3MSep '26

Annual revenue

$321.2MFY20$430.9MFY21$512.1MFY22$512.3MFY23$573.3MFY24$568.1MFY25

Profitability & balance sheet

Gross margin68.7%
Operating margin10.1%
Net margin9.8%
Return on equity28.2%
Return on assets8.3%
Return on invested capital14.1%
Current ratio1.68
Liabilities / assets56.7%
Cash & investments$30.71M
Total debt$229.83M
Net cash (debt)-$199.12M
Free cash flow / sales14.5%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Pain Treatments$71.34M 50.1%
  • Surgical Solutions$50.52M 35.5%
  • Restorative Therapies$20.59M 14.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $142.44M $153.21M $132.09M $568.09M $157.90M
Total Operating Revenue $142.44M $153.21M $132.09M $568.09M $157.90M
Cost of Revenue $45.31M $47.54M $41.32M $179.93M $49.12M
Gross Profit $97.13M $105.67M $90.77M $388.16M $108.78M
Operating Expense $87.43M $86.95M $81.90M $331.87M $87.06M
Selling and Admin Expenses $82.95M $82.74M $78.33M $314.03M $82.76M
Research & Development $3.44M $3.17M $2.47M $12.11M $3.01M
Depreciation & Amortization & Depletion $1.05M $1.04M $1.11M $5.73M $1.30M
-Depreciation & Amortization $1.05M $1.04M $1.11M $5.73M $1.30M
Operating Profit $9.70M $18.71M $8.87M $56.29M $21.72M
Net Non-Operating Interest Income (Expense) -$3.76M -$4.07M -$4.33M -$26.49M -$5.31M
Non-Operating Interest Expense $3.76M $4.07M $4.33M $26.49M $5.31M
Other Income (Expense) $216,000.00 $664,000.00 -$27,000.00 -$4.10M -$2.27M
Special Income (Charges) $0.00 $415,000.00 -$454,000.00 -$2.64M -$2.24M
-Less:Restructuring and Mergern & Acquisition $0.00 -$415,000.00 $454,000.00 $2.24M $2.24M
-Gain on Sale of Property/Plant/Equipment $0.00 $0.00 $0.00 -$81,000.00 $0.00
Other Non-Operating Income (Expenses) $216,000.00 $249,000.00 $427,000.00 -$1.45M -$37,000.00
Pretax Profit $6.16M $15.31M $4.52M $25.71M $14.14M
Tax -$701,000.00 -$20.90M $571,000.00 -$1.57M -$3.18M
Net Profit $6.86M $36.21M $3.95M $27.27M $17.32M
Profit from Continuing Operations $6.86M $36.21M $3.95M $27.27M $17.32M
Minority Interests $872,000.00 $2.76M $833,000.00 $4.54M $2.56M
Net Income to Parent Company $5.99M $33.44M $3.11M $22.73M $14.76M
Net Income to Common Stockholders $5.99M $33.44M $3.11M $22.73M $14.76M
Basic EPS $0.09 $0.49 $0.05 $0.34 $0.22
Diluted EPS $0.08 $0.47 $0.04 $0.33 $0.21
-Less:Impairment of Capital Assets – – – $0.00 $0.00
-Less:Other Special Charges – – – $326,000.00 $0.00
Net Income from Discontinuous Operations – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $673.43M $673.35M $650.54M $683.56M $683.56M
Total Current Assets $265.54M $257.53M $249.81M $272.84M $272.84M
Cash and Cash Equivalents & Short-Term Investments $30.71M $29.46M $35.85M $51.24M $51.24M
-Cash and Cash Equivalents $30.71M $29.46M $35.85M $51.24M $51.24M
Receivables $138.23M $138.41M $120.53M $128.30M $128.30M
-Accounts Receivable $138.23M $138.41M $120.53M $128.30M $128.30M
Inventory $83.10M $79.81M $83.19M $82.24M $82.24M
Other Current Assets $13.51M $9.86M $10.26M $11.07M $11.07M
Total Non-Current Assets $407.89M $415.82M $400.73M $410.72M $410.72M
Net PPE $23.54M $24.75M $25.98M $27.02M $27.02M
-Gross PPE $23.54M $24.75M $25.98M $81.29M $81.29M
Goodwill and Other Intangible Assets $351.39M $358.51M $367.12M $375.88M $375.88M
-Goodwill $7.46M $7.46M $7.46M $7.46M $7.46M
-Other Intangible Assets $343.93M $351.05M $359.66M $368.42M $368.42M
Non-Current Deferred Assets $29.54M $29.05M $5.52M $5.52M $5.52M
Other Non-Current Assets $3.42M $3.51M $2.10M $2.29M $2.29M
Total Liabilities $381.56M $395.93M $416.27M $455.11M $455.11M
Total Current Liabilities $157.70M $152.45M $148.10M $160.38M $160.38M
Payables $31.51M $26.36M $28.86M $16.06M $16.06M
-Accounts Payable $25.79M $20.20M $24.05M $10.93M $10.93M
-Total Tax Payable $5.72M $6.16M $4.81M $5.14M $5.14M
Current Accrued Expenses $79.02M $78.05M $74.20M $101.70M $101.70M
Short-Term Debt and Capital Lease Obligation $18.75M $18.75M $18.75M $15.00M $15.00M
-Current Debt $18.75M $18.75M $18.75M $15.00M $15.00M
Other Current Liabilities $23.03M $22.43M $20.09M $21.06M $21.06M
Total Non-Current Liabilities $223.85M $243.48M $268.18M $294.73M $294.73M
Long Term Debt and Capital Lease Obligation $211.08M $229.70M $253.33M $278.95M $278.95M
-Long Term Debt $211.08M $229.70M $253.33M $278.95M $278.95M
Non-Current Deferred Liabilities $568,000.00 $568,000.00 $568,000.00 $433,000.00 $433,000.00
Other Non-Current Liabilities $12.21M $13.21M $14.29M $15.35M $15.35M
Total Equity $291.87M $277.41M $234.27M $228.45M $228.45M
Stockholders' Equity $240.50M $228.31M $188.90M $184.11M $184.11M
Capital Stock $85,000.00 $84,000.00 $84,000.00 $83,000.00 $83,000.00
-Common Stock $85,000.00 $84,000.00 $84,000.00 $83,000.00 $83,000.00
Additional Paid-In Capital $532.95M $527.93M $522.91M $520.85M $520.85M
Retained Earnings -$292.39M -$298.38M -$331.82M -$334.93M -$334.93M
Gains/Losses Not Affecting Retained Earnings -$148,000.00 -$1.33M -$2.28M -$1.90M -$1.90M
Minority Interests $51.38M $49.11M $45.36M $44.34M $44.34M
-Accumulated Depreciation – – – -$54.26M -$54.26M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $20.66M $19.87M $8.93M $74.67M $37.97M
Net cash flow from continuing operations $20.66M $19.87M $8.93M $74.67M $37.97M
Net Income from Continuing Operations $6.86M $36.21M $3.95M $27.27M $17.32M
Gain/Loss from Continuing Operations $43,000.00 $54,000.00 $54,000.00 $47,000.00 -$27,000.00
Depreciation & Depletion & Amortization $10.32M $10.95M $11.21M $47.01M $11.69M
Deferred Tax -$487,000.00 -$22.29M $135,000.00 -$909,000.00 -$1.13M
Other Non-Cash Items $63,000.00 $170,000.00 $275,000.00 $1.16M $155,000.00
Change in Working Capital -$935,000.00 -$10.17M -$10.18M -$13.84M $6.21M
-Change in Receivables $152,000.00 -$17.94M $7.32M -$916,000.00 $1.89M
-Change in Inventory -$3.53M $2.96M -$2.65M $8.57M $12.97M
-Change in Payables and Accrued Expense $4.10M $3.82M -$15.37M -$19.81M -$4.44M
-Change In Other Working Capital -$1.65M $990,000.00 $522,000.00 -$1.68M -$4.20M
Net cash flow from investing -$1.83M -$2.46M -$574,000.00 -$3.25M -$580,000.00
Net Cash Flow from Continuing Investing Activities -$1.83M -$2.46M -$574,000.00 -$3.25M -$580,000.00
Net PPE Purchase and Sale -$334,000.00 -$960,000.00 -$574,000.00 -$2.56M -$580,000.00
Net Business Purchase and Sale $0.00 – – -$686,000.00 $0.00
Net Investment Purchase and Sale -$1.50M – – $0.00 $0.00
Financing Cash Flow -$17.58M -$23.43M -$23.14M -$62.14M -$28.45M
Net Cash Flow from Continuing Financing Activities -$17.58M -$23.43M -$23.14M -$62.14M -$28.45M
Net Issuance Payments Of Debt -$18.75M -$23.75M -$22.00M -$42.91M -$28.75M
Net Common Stock Issuance $1.42M $853,000.00 $120,000.00 $2.07M $511,000.00
Net Other Financing Charges -$248,000.00 -$535,000.00 -$1.26M -$21.30M -$208,000.00
Ending Cash Balance $30.71M $29.46M $35.85M $51.24M $51.24M
Net Change in Cash $1.24M -$6.02M -$14.78M $9.29M $8.94M
Beginning Cash Balance $29.46M $35.85M $51.24M $41.58M $42.16M
Effect of Exchange Rate Changes $11,000.00 -$370,000.00 -$608,000.00 $371,000.00 $133,000.00
Free Cash Flow $20.32M $18.91M $8.36M $72.11M $37.39M
Cash Flow from Discontinued Operating Activities – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on BVS.

Sign in to join the discussion.

Scroll to Top